V600E突变-话题@MedSci

#V600E突变#

19篇内容 | 1046人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2186168, encodeId=b58c21861689e, content=<a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=6de63659ed' target=_blank style='color:#2F92EE;'>#BRAF#</a> <a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a> <a href='/topic/show?id=48df110942b2' target=_blank style='color:#2F92EE;'>#ALK点突变#</a> <a href='/topic/show?id=867c110943c8' target=_blank style='color:#2F92EE;'>#布格替尼#</a>, objectTitle=HIP-ALK重排肺腺癌经治后继发BRAF V600E突变和ALK点突变，最终获益布格替尼, objectType=article, longId=812420, objectId=2ac4812420f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017232524_4754896.png, objectUrl=/article/show_article.do?id=2ac4812420f4, replyNumber=0, likeNumber=86, createdTime=2024-02-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=2ac4812420f4, moduleTitle=HIP-ALK重排肺腺癌经治后继发BRAF V600E突变和ALK点突变，最终获益布格替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ac4812420f4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2086233, encodeId=bd4e20862337a, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效, objectType=article, longId=295362, objectId=66af295362ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66af295362ac, replyNumber=0, likeNumber=81, createdTime=2022-12-05, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66af295362ac, moduleTitle=Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66af295362ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086234, encodeId=7bb2208623422, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Clinical Colorectal Cancer:BRAF抑制剂encorafenib(康奈非尼)联合西妥昔单抗治疗经治的BRAFV600E突变转移性结直肠癌的疗效, objectType=article, longId=727754, objectId=ef63e277540f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef63e277540f, replyNumber=0, likeNumber=73, createdTime=2022-08-06, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef63e277540f, moduleTitle=Clinical Colorectal Cancer:BRAF抑制剂encorafenib(康奈非尼)联合西妥昔单抗治疗经治的BRAFV600E突变转移性结直肠癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef63e277540f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086232, encodeId=3f502086232b8, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, objectType=article, longId=221246, objectId=2b0d221246c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d221246c4, replyNumber=0, likeNumber=74, createdTime=2022-08-28, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d221246c4, moduleTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d221246c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086230, encodeId=8d4820862300a, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=J Clin Oncol：Encorafenib+西妥昔单抗，BRAF V600E突变型转移性结直肠癌患者的新选择！, objectType=article, longId=206364, objectId=b9a1206364ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9a1206364ab, replyNumber=0, likeNumber=67, createdTime=2021-12-07, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9a1206364ab, moduleTitle=J Clin Oncol：Encorafenib+西妥昔单抗，BRAF V600E突变型转移性结直肠癌患者的新选择！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9a1206364ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086231, encodeId=4fe02086231ad, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新, objectType=article, longId=217037, objectId=f9ca21e03751, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ca21e03751, replyNumber=0, likeNumber=54, createdTime=2022-08-26, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ca21e03751, moduleTitle=J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ca21e03751)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086229, encodeId=52c420862297c, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Br J Cancer：BRAF V600E突变型结直肠癌患者的耐药性相关研究, objectType=article, longId=203687, objectId=cac520368eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cac520368eb0, replyNumber=0, likeNumber=99, createdTime=2021-02-07, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cac520368eb0, moduleTitle=Br J Cancer：BRAF V600E突变型结直肠癌患者的耐药性相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cac520368eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086228, encodeId=f7de208622800, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Lancet oncol：达拉非尼联合曲美替尼治疗BRAF V600E突变的胆管癌, objectType=article, longId=199739, objectId=ef2c199e3957, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef2c199e3957, replyNumber=0, likeNumber=79, createdTime=2020-10-07, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2c199e3957, moduleTitle=Lancet oncol：达拉非尼联合曲美替尼治疗BRAF V600E突变的胆管癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef2c199e3957)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086225, encodeId=41562086225dd, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗, objectType=article, longId=175233, objectId=c5631e5233ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5631e5233ba, replyNumber=0, likeNumber=63, createdTime=2020-03-13, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5631e5233ba, moduleTitle=BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5631e5233ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086227, encodeId=35b8208622e68, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=NEJM：Encodrafenib、Binimetinib联合西妥昔单抗用于BRAFV600E突变结直肠癌, objectType=article, longId=181909, objectId=dfaf18190961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfaf18190961, replyNumber=0, likeNumber=88, createdTime=2019-11-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfaf18190961, moduleTitle=NEJM：Encodrafenib、Binimetinib联合西妥昔单抗用于BRAFV600E突变结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfaf18190961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086226, encodeId=e3fc2086226a7, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Clinica Chimica Acta：用液滴数字PCR检测乳头状甲状腺癌细针穿刺液中BRAF V600E突变, objectType=article, longId=177023, objectId=72ff1e702301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72ff1e702301, replyNumber=0, likeNumber=69, createdTime=2019-08-31, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72ff1e702301, moduleTitle=Clinica Chimica Acta：用液滴数字PCR检测乳头状甲状腺癌细针穿刺液中BRAF V600E突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72ff1e702301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086222, encodeId=83a52086222da, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Clin Oral Investig：免疫组化分析成釉细胞瘤中的BRAF V600E突变, objectType=article, longId=139868, objectId=d6e31398680b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6e31398680b, replyNumber=0, likeNumber=73, createdTime=2019-04-24, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6e31398680b, moduleTitle=Clin Oral Investig：免疫组化分析成釉细胞瘤中的BRAF V600E突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6e31398680b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086224, encodeId=43c6208622496, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=【ASCO-GI 2019】抢先看！达拉非尼联合曲美替尼在BRAF V600E突变的胆管癌患者中的研究, objectType=article, longId=158427, objectId=4af815842edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4af815842edc, replyNumber=0, likeNumber=125, createdTime=2019-03-08, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4af815842edc, moduleTitle=【ASCO-GI 2019】抢先看！达拉非尼联合曲美替尼在BRAF V600E突变的胆管癌患者中的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4af815842edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086223, encodeId=3800208622325, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=JCO：男性甲状腺乳头状癌预后是否更差？BRAF V600E突变说了算, objectType=article, longId=146521, objectId=b8dc14652188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8dc14652188, replyNumber=0, likeNumber=0, createdTime=2019-03-31, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8dc14652188, moduleTitle=JCO：男性甲状腺乳头状癌预后是否更差？BRAF V600E突变说了算, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8dc14652188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086220, encodeId=66f820862205f, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义, objectType=article, longId=106880, objectId=74481068808f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74481068808f, replyNumber=0, likeNumber=90, createdTime=2017-09-12, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74481068808f, moduleTitle=J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74481068808f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086217, encodeId=d714208621ef0, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=SCI REP：甲状腺乳头状癌患者BRAF V600E突变和超声特征之间的关联！, objectType=article, longId=104992, objectId=fd9210499218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd9210499218, replyNumber=0, likeNumber=71, createdTime=2018-04-04, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd9210499218, moduleTitle=SCI REP：甲状腺乳头状癌患者BRAF V600E突变和超声特征之间的关联！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd9210499218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086218, encodeId=6a5020862185d, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=JCO：小儿低级别胶质瘤BRAF V600E突变对治疗及预后影响, objectType=article, longId=106281, objectId=877510628133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877510628133, replyNumber=0, likeNumber=69, createdTime=2018-05-10, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877510628133, moduleTitle=JCO：小儿低级别胶质瘤BRAF V600E突变对治疗及预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877510628133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086221, encodeId=18f320862219a, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=Oral Oncol：牙源性角化囊肿与致癌基因BRAF V600E突变频率的关系, objectType=article, longId=121600, objectId=96cc121600cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96cc121600cb, replyNumber=0, likeNumber=72, createdTime=2018-02-12, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96cc121600cb, moduleTitle=Oral Oncol：牙源性角化囊肿与致癌基因BRAF V600E突变频率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96cc121600cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086219, encodeId=23f0208621934, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=【重复了】J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义, objectType=article, longId=106854, objectId=475810685479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=475810685479, replyNumber=0, likeNumber=77, createdTime=2018-06-17, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=475810685479, moduleTitle=【重复了】J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=475810685479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2086216, encodeId=b7eb2086216e4, content=<a href='/topic/show?id=ed621824388' target=_blank style='color:#2F92EE;'>#V600E突变#</a>, objectTitle=JAMA：BRAF V600E突变与乳头状甲状腺癌显著相关, objectType=article, longId=17478, objectId=104b1e478d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=104b1e478d0, replyNumber=0, likeNumber=64, createdTime=2013-05-17, rootId=0, userName=jj000001, userId=8942242, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=104b1e478d0, moduleTitle=JAMA：BRAF V600E突变与乳头状甲状腺癌显著相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=104b1e478d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

V600E突变

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肺癌# #BRAF# #V600E突变# #ALK点突变# #布格替尼#

HIP-ALK重排肺腺癌经治后继发BRAF V600E突变和ALK点突变，最终获益布格替尼

2024-02-06发表于陕西省

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效

2022-12-05

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

Clinical Colorectal Cancer:BRAF抑制剂encorafenib(康奈非尼)联合西妥昔单抗治疗经治的BRAFV600E突变转移性结直肠癌的疗效

2022-08-06

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效

2022-08-28

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

J Clin Oncol：Encorafenib+西妥昔单抗，BRAF V600E突变型转移性结直肠癌患者的新选择！

2021-12-07

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

J Thorac Oncol：达拉非尼+曲美替尼治疗转移性BRAF V600E突变非小细胞肺癌的疗效：5年生存结果更新

2022-08-26

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

Br J Cancer：BRAF V600E突变型结直肠癌患者的耐药性相关研究

2021-02-07

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

Lancet oncol：达拉非尼联合曲美替尼治疗BRAF V600E突变的胆管癌

2020-10-07

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

BRAF、EGFR、MEK，三靶向无化疗方案或成为BRAF V600E突变型mCRC新标准治疗

2020-03-13

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

NEJM：Encodrafenib、Binimetinib联合西妥昔单抗用于BRAFV600E突变结直肠癌

2019-11-08

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

Clinica Chimica Acta：用液滴数字PCR检测乳头状甲状腺癌细针穿刺液中BRAF V600E突变

2019-08-31

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

Clin Oral Investig：免疫组化分析成釉细胞瘤中的BRAF V600E突变

2019-04-24

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

【ASCO-GI 2019】抢先看！达拉非尼联合曲美替尼在BRAF V600E突变的胆管癌患者中的研究

2019-03-08

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

JCO：男性甲状腺乳头状癌预后是否更差？BRAF V600E突变说了算

2019-03-31

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义

2017-09-12

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

SCI REP：甲状腺乳头状癌患者BRAF V600E突变和超声特征之间的关联！

2018-04-04

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

JCO：小儿低级别胶质瘤BRAF V600E突变对治疗及预后影响

2018-05-10

爆笑小医 (审核中...)

前往app查看评论内容

#V600E突变#

Oral Oncol：牙源性角化囊肿与致癌基因BRAF V600E突变频率的关系

2018-02-12

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

【重复了】J Clin Oncol：儿童低级别胶质瘤中BRAF V600E突变对治疗和预后的意义

2018-06-17

jj000001 (审核中...)

前往app查看评论内容

#V600E突变#

JAMA：BRAF V600E突变与乳头状甲状腺癌显著相关

2013-05-17

科室
- - 订阅+
  - 更多科室
工具
服务